Chem. J. Chinese Universities ›› 2012, Vol. 33 ›› Issue (02): 378.doi: 10.3969/j.issn.0251-0790.2012.02.029

• Physical Chemistry • Previous Articles     Next Articles

Gd3+ and RGD Functionalized Quantum Dots for Fluorescent and MR Dual-modality Imaging of Pancreatic Cancer Cells

LIU Feng-Jun1, ZHANG Bing-Bo2, SONG Ge1, CHENG Ying-Sheng1   

  1. 1. Medical Imaging Center, the Tenth People's Hospital of Tongji University, Shanghai 200072, China;
    2. Institute for Advanced Materials & Nano Biomedicine, Tongji University, Shanghai 200092, China
  • Received:2011-03-11 Online:2012-02-10 Published:2012-01-13
  • Contact: Bo BingZHANG E-mail:bingbozhang@tongji.edu.cn;cjr.chengysh@vip.163.com

Abstract: Though early diagnosis of pancreatic cancer is difficult, it brings challenges and opportunities to the molecular imaging. The existing diagnostic imaging technologies are limited as a result of single functiona-lity, making it difficult for accurate diagnosis. In this work, magnetic resonance image(MRI) and fluorescence imaging were combined by several key contrast agents including gadolinium ion, quantum dots(QDs) and arginine(R)-glycine(G)-D-aspartic acid(D)(RGD) for high relaxation rate, strong fluorescent emission and good targeting. The integrated dual-modality QDs@Gd3+-RGD nanoprobes were used for dual-modality imaging of pancreatic cancer cells. TEM and dynamic light scattering(DLS) results indicate complete dispersion of QDs@Gd3+-RGD nanoprobes in water. In vitro relaxivity measurement shows high relaxation rate of QDs@Gd3+-RGD nanoprobes. Their r1 and r2 are 7.6 and 9.5 L@mmol-1@s-1, respectively. Fluorescent and MR dual-modality imaging suggest the prepared QDs@Gd3+-RGD nanoprobes can sever as both fluorescent and MR imaging of patu8988 pancreatic cancer cells.

Key words: Dual-modality imaging, Quantum dots, Arginine(R)-glycine(G)-D-aspartic acid(D)(RGD), Pancreatic cancer

CLC Number: 

TrendMD: